Showing results (1751-1760 of 1,969) with videos related to

Sort By:
Pageof 197
AIDS Research and Human Retroviruses|January 9, 2010
Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in ItalyChiara Riva, Alessia Lai, Ilaria Caramma, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
European Journal of Emergency Medicine : Official Journal of the European Society for Emergency Medicine|January 28, 1998
Emergency medical services in mass gatherings: the experience of the Formula 1 Grand Prix 'San Marino' in ImolaR Nardi, M Bettini, C Bozzoli, et al.
Frontiers in Immunology|December 28, 2020
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical MonocytesAndrea Lombardi, Elena Trombetta, Alessandra Cattaneo, et al.
Circulation. Cardiovascular Interventions|December 15, 2016
Clinical Impact of Suboptimal Stenting and Residual Intrastent Plaque/Thrombus Protrusion in Patients With Acute Coronary Syndrome: The CLI-OPCI ACS Substudy (Centro per la Lotta Contro L'Infarto-Optimization of Percutaneous Coronary Intervention in Acute Coronary Syndrome)Francesco Prati, Enrico Romagnoli, Laura Gatto, et al.
Scientific Reports|March 2, 2021
Impact of SARS-CoV-2 infection on the recovery of peripheral blood mononuclear cells by density gradientMaria D I Manunta, Giuseppe Lamorte, Francesca Ferrari, et al.
Immunity & Ageing : I & A|August 12, 2023
Systemic immune response in young and elderly patients after traumatic brain injuryMarta Magatti, Francesca Pischiutta, Fabrizio Ortolano, et al.
American Heart Journal|December 19, 2015
Randomized evaluation of intralesion versus intracoronary abciximab and aspiration thrombectomy in patients with ST-elevation myocardial infarction: The COCTAIL II trialFrancesco Prati, Enrico Romagnoli, Ugo Limbruno, et al.
Gut|February 1, 2020
Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarkerGuido Alessandro Baselli, Paola Dongiovanni, Raffaela Rametta, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 12, 2014
Adjuvant low-dose interleukin-2 (IL-2) plus interferon-α (IFN-α) in operable renal cell carcinoma (RCC): a phase III, randomized, multicentre trial of the Italian Oncology Group for Clinical Research (GOIRC)Rodolfo Passalacqua, Caterina Caminiti, Sebastiano Buti, et al.
Pageof 197